NEW YORK , July 20, 2022 /PRNewswire/ --As per Zion Market Research study, The global bioprocess technology market size was worth over USD 18 billion in 2021 and is predicted to grow to around USD 79 billion by 2028 with a compound annual growth rate (CAGR) of roughly 15% between 2022 and 2028.
Bioprocess technology refers to the industrial applications of biological processes that involve working on living cells or their components to reach desired substrates transformation. The advanced technology is used extensively in pharmaceuticals, fuels, chemicals, food, flavors, and other industries with the help of enzymes, microorganisms, animal cells, or plant cells in a bioreactor. Bioprocess technology is gaining more momentum as compared to traditional techniques because of its various benefits like the requirement of milder reaction conditions along with the production of renewable by-products or biomass. These technologies are more efficient and specific as compared to conventional chemical processes.
Bioprocess technology is the backbone of biotechnology since it aids the translation of life sciences into industrial products that are highly advanced. The general stages of bioprocess technology include the production of media or substrates, followed by biocatalysts that lead to volume production. The last few steps include downstream processing which entails purification-related procedures before entering the final stage of processing. The global market is witnessing a surging growth in 2 major applications of bioprocess technology, namely: fructooligosaccharides and galactooligosaccharides. They are predicted to bring tremendous changes in the food industry due to the various health benefits associated with them.
Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.zionmarketresearch.com/sample/bioprocess-technology-market
Our Free Sample Report Includes:
2022 Updated Report Introduction, Overview, and In-depth industry analysis
COVID-19 Pandemic Outbreak Impact Analysis Included
214 + Pages Research Report (Inclusion of Updated Research)
Provide Chapter-wise guidance on Request
2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
Includes Updated List of tables & figures
Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
Key Industry Insights & Finding of the Bioprocess Technology Market Reports:
As per the analysis shared by our research analyst, the Bioprocess Technology Market is expected to grow annually at a CAGR of around 15 % (2022-2028).
Through the primary research, it was established that the Bioprocess Technology Market was valued approximately USD 18 Billion in 2021 and is projected to reach to roughly USD 79 Billion by 2028.
The global bioprocess technology market was dominated by North America in 2021 and is anticipated to follow the same trend owing to the increased geriatric population along with the presence of many bioprocess technology manufacturers in regions like the USA and Canada .
North America held over 85% of the global market revenue in 2021 owing to increased living standards and the corresponding disposable income of the general population encouraging them to spend on medical treatment.
Europe holds a considerable amount of global market share majorly driven due to the ever-expanding pharmaceutical sector along with rising demand for monoclonal antibodies, biosimilar, and recombinant proteins.
Realizing the safety concerns related to bioprocess technologies, various governments along with international healthcare agencies have laid down strict rules & regulations to be adhered to when working with such technologies or in organizations that employ bioprocess technology.
Zion Market Research published the latest report titled as "Global Bioprocess Technology Market By Application (Specialty products, Environment Management Aid, Biopharmaceuticals, and Industrial Chemicals), By Type (Cell Expansion, Cell Culture, Cell Line Development, Flow Cytometry, and Virus Infiltration), By End-User (Medical Institutions, Research Laboratories & Centers, and Hospitals), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028." into their research database.
Bioprocess Technology Market: Growth Drivers
Increased use of bioprocess technologies in the food and pharmaceutical sector to aid global market growth.
The global bioprocess technology market is projected to register higher growth in the coming years due to the extensive use of these technologies in two of the fastest-growing industries that are the food sector and the pharmaceutical sector. Since bioprocessing is a natural and one of the safest ways in which food manufacturers can manufacture items like cheese, wine, beer, bread, and yogurt that are staples in almost all diet forms, bioprocess technology has immense application in this sector. In the pharmaceutical sector, biomedical research and subsequent processes are used to pave the way for innovative pharmaceutical products which have huge implications on the healthcare sector. Since the industry is facing immense pressure due to higher demands, lesser time to deliver, and increased cost, the global market is receiving heavy input from key players to upgrade bioprocess technologies that will ultimately help them meet the growing medical needs.
The global market growth can also be attributed to the rising demand for specialized and disease-centric treatments propelling the need to invest in bioprocess therapies like cell therapy. The growing research on recombinant DNA technology which has huge utilization of bioprocess technology may also aid the expansion of the global market.
Stringent government regulations to restrain the global market growth.
Bioprocesses can lead to serious health hazards when handled carelessly. These technologies can leave long-lasting negative implications globally in case of misuse. Realizing the safety concerns related to bioprocess technologies, various governments along with international healthcare agencies have laid down strict rules & regulations to be adhered to when working with such technologies or in organizations that employ bioprocess technology. In the food sector, the approval process before any food items are rolled out in the market is extremely strict and can lead to the shutting down of entire manufacturing units in case of malpractice which is also applicable to the pharmaceutical sector. This is expected to restrict the global market growth during the coming years.
Directly Purchase a Copy of the Report @ https://www.zionmarketresearch.com/buynow/su/bioprocess-technology-market
Strategic decision by market players to provide growth opportunities for global market expansion.
Since some countries have stricter laws in comparison to others, global market leaders have been adopting various strategic methods to penetrate the world market involving mergers & acquisitions, collaborations, and tie-ups, to name a few of these practices. Outsourcing the bioprocess required is a strategy showing exemplary results and is expected to provide lucrative growth opportunities in the global bioprocess technology market.
The global market may also find better growth chances owing to the rising demand for single-use bioprocess systems since they offer cost & time efficiency and can deliver better results.
High cost of the bioprocess technology may challenge global market growth.
Large-scale bioproduction is extremely labor-intensive, requires high funds, and is time-consuming as compared to non-bioprocess technologies. This is because of the multiple variables that are involved along with many individual processes. Protein purification is one of the costliest expenses in the whole bioprocess production and comprises more than 50% of the total cost making it difficult for small-scale manufacturers to utilize the technology. In emerging economies, the cost becomes even higher since the majority of the bioprocess technology has to be imported leading to challenging situations for global market expansion.
Global Bioprocess Technology Market: Segmentation
The global bioprocess technology market is segmented by application, type, end-user, and region.
By application, the global market segments are specialty products, environment management aid, biopharmaceuticals, and industrial chemicals. Due to the rise in the number of infectious as well as chronic diseases, the global market is expected to be led by the biopharmaceutical sector. The sector contributed over USD 400 billion in 2021 and is expected to grow even more in the next few years.
By type, the global market is segmented into cell expansion, cell culture, cell line development, flow cytometry, and virus infiltration. Cell culture bioprocessing may dominate the global market due to increased research and production of therapeutic proteins in the healthcare sector.
Based on end-users, the global market is divided into medical institutions, research laboratories & centers, and hospitals. The global highest revenue may generate from the research laboratories owing to growing investments towards research on medicines, diseases, and other future biomedical problems.
Get More Insight before Buying@: https://www.zionmarketresearch.com/inquiry/bioprocess-technology-market
List of Key Players of Bioprocess Technology Market:
GE Healthcare (General Electric Company)
Key questions answered in this report:
What are the growth rate forecast and market size for Bioprocess Technology Market?
What are the key driving factors propelling the Bioprocess Technology Market forward?
What are the most important companies in the Bioprocess Technology Market Industry?
What segments does the Bioprocess Technology Market cover?
How can I receive a free copy of the Bioprocess Technology Market sample report and company profiles?
By Product Type, By Application, and By End Use
Value (USD Billion), and Volume (Units)
Revenue in USD million/billion and CAGR from 2022 to 2028
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Lonza, GE Healthcare (General Electric Company), Thermo Fisher Scientific, IncSartorius AG, Eppendorf AG, Dickinson and Company, Becton, Siemens Healthineers, Nova Biomedical, Advanced Instruments, F. Hoffmann-La Roche Ltd., and Danaher Corporation.
Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Avail customized purchase options to meet your exact research needs.
https://www.zionmarketresearch.com/custom/1560
Free Brochure: https://www.zionmarketresearch.com/requestbrochure/bioprocess-technology-market
In September 2021 , a one-of-a-kind bathroom tissue and paper towel were launched by Cascades in the USA and Canada . The bathroom products will comprise 100% recycled plastic packaging. Cascades is a leader in the circular economy, and with the launching of the new packaging systems, it intends to reduce the environmental impacts of its operations. The launch was accompanied by excellent promotional campaigns.
In November 2020 , LTC Group was acquired by Accrol. LTC Group manufactures tissue converters. With this acquisition, Accrol intends to increase the good scale business with the help of modern machine assets that are high-quality and will aid the day-to-day operations.
North America to provide excellent growth opportunities during the forecast period.
The global bioprocess technology market was dominated by North America in 2021 and is anticipated to follow the same trend owing to the increased geriatric population along with the presence of many bioprocess technology manufacturers in regions like the USA and Canada . North America held over 85% of the global market revenue in 2021 owing to increased living standards and the corresponding disposable income of the general population encouraging them to spend on medical treatment. The regional growth may also be attributed to the advanced economy and growing funding for research activities.
Europe holds a considerable amount of global market share majorly driven due to the ever-expanding pharmaceutical sector along with rising demand for monoclonal antibodies, biosimilar, and recombinant proteins. The region may also witness high growth because of excellent medical reimbursement policies.
Global Bioprocess Technology Market is segmented as follows:
Bioprocess Technology Market: By Application Outlook (2022-2028)
Bioprocess Technology Market: By Type Outlook (2022-2028)
Bioprocess Technology Market: By End-User Outlook (2022-2028)
Bioprocess Technology Market: By Region Outlook (2022-2028)
Rest of Middle East & Africa
Press Release For Bioprocess Technology Market: https://www.zionmarketresearch.com/news/global-bioprocess-technology-market
Browse Other Related Research Reports from Zion Market Research
Endocrine Peptide Test Market - Global Industry Analysis: The global endocrine peptide test market was worth around $7.04 billion in 2021 and is predicted to grow to around $11 billion by 2028 at a CAGR rate of 8% over the forecast period.
Hospital-Acquired Infection Control Market - Global Industry Analysis: The global hospital-acquired infection control market was valued at USD 28.99 billion in 2021. The global market is projected to grow to about USD 34.03 billion at a CAGR of 9.89% by 2028.
Healthcare E-Commerce Market - Global Industry Analysis: The global Healthcare E-Commerce Market accrued earnings worth approximately 353.1 (USD Billion) in 2020 and is predicted to gain revenue of about 840.1 (USD Billion) by 2028, is set to record a CAGR of nearly 17.1% over the period from 2021 to 2028.
Browse through Zion Market Research's coverage of the Global Healthcare Industry
Follow Us on: LinkedIn | Twitter | Facebook
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research 244 Fifth Avenue, Suite N202 New York , 10001, United States Tel: +49-322 210 92714 USA /Canada Toll Free No.1-855-465-4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com/ Blog: https://techpru.com/ | http://thehealthypandas.com/
Logo: https://mma.prnewswire.com/media/1605489/Zion_Market_Research_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/at-15-cagr-bioprocess-technology-market-size-to-hit-us-79-billion-globally-by-2028--industry-trends-share-growth-rate-value-analysis--forecast-report-by-zion-market-research-301590183.html
Cleveland-Cliffs (CLF) delivered earnings and revenue surprises of -2.24% and 4.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
In this article, we discuss the 10 stocks that Jim Cramer is talking about. If you want to read about some more stocks that Jim Cramer is talking about, go directly to Jim Cramer Is Talking About These 5 Stocks. Recession fears in the United States have reached fever pitch as even veteran stock market […]
Snap stock is falling double digits after a dismal second-quarter earnings report.
When Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett speaks, Wall Street pays close attention. The easiest way for investors to monitor what Warren Buffett has been buying and selling is to track Berkshire Hathaway's quarterly 13F filings with the Securities and Exchange Commission (SEC).
Snap's 40% stock price crash on Friday after a dismal second quarter earnings report and brutal call is well warranted, one analysts explained to Yahoo Finance.
Rivian Automotive (NASDAQ: RIVN) was one of the hottest electric vehicle stocks of 2021. The EV maker went public at $78 per share last November, and its stock started trading at $106.75 before skyrocketing to an all-time high of $172.01 a week later. Rivian initially attracted so much attention because it was backed by Amazon (NASDAQ: AMZN) and Ford (NYSE: F).
Verizon is set for its worst week since October 2008, but it's sitting on must-hold support right now.
IBM (IBM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Michael Burry, who bet on the collapse of subprime credit, does not hesitate to give his opinion on market developments.
In this article, we discuss the 10 stocks to buy before their earnings reports. If you want to read about some more stocks expected to gain following their quarterly results, go directly to 5 Stocks to Buy Before Their Earnings Reports. With the inflation in the US at a 40-year high and the Federal Reserve […]
Yahoo Finance's Ines Ferré breaks down how stocks are trading on Friday afternoon as the Nasdaq lags following Snap earnings.
ARKK ETF had a tough day, with nearly all of its holdings aside from Tesla in the red.
The average of price targets set by Wall Street analysts indicates a potential upside of 38.9% in Devon Energy (DVN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Stock-market bulls are poking their heads above the parapet, but skeptics see little more than a bear-market bounce.
After more than a year of testing in select cities, Amazon is launching its first wave of custom electric delivery vehicles.
VALE S.A. (VALE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
(Bloomberg) -- Verizon Communications Inc. shares plunged to their biggest drop in 14 years after the mobile-phone company cut its forecast for the second straight quarter, adding to concerns that consumers are pulling back on spending.Most Read from BloombergThree Arrows Founders Break Silence Over Collapse of Crypto Hedge FundTrump Insiders Recall How He Spurned Pleas to Act as Riot RagedAmericans Who Can’t Afford Homes Are Moving to Europe InsteadMusk Lieutenant Scrutinized in Internal Tesla
When a company creates a significant amount of value over the long term, its stock price generally delivers strong gains. To bring their shares back into easier reach for retail investors, companies can conduct stock splits, and in 2022, a host of big technology companies are doing just that. Google parent Alphabet (NASDAQ: GOOGL)(NASDAQ: GOOG) was the most recent.
A recent rally in Tesla shares has meant serious pain for short-sellers who have so far had a successful year betting against Elon Musk.
Shares of SoFi Technologies (NASDAQ: SOFI), Upstart (NASDAQ: UPST), and Affirm Holdings (NASDAQ: AFRM) rose double-digits this week, up 11.9%, 10.6%, and 29%, respectively, as of the end of Thursday's trading. Each had already seen their shares under pressure heading into this week due to inflation fears and negative analyst notes during the week prior. Additionally, both Upstart, which uses artificial intelligence to underwrite loans, as well as Affirm, a buy-now-pay-later platform, each received negative reviews from Goldman Sachs' (NYSE: GS) fintech analyst Michael Ng.